Evaluation of a protocol to select patients of all ages for cardioversion from atrial fibrillation

Age and Ageing

Volumn 26, Issue 4, 1997, Pages 247-252

  Lawson Matthew, Peter J ^a,b   Ionescu, Adrian ^a   Mchugh, Patrick ^a   Channer, Kevin S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation; Cardioversion; Protocol

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL PROTOCOL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SINUS RHYTHM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CORONARY CARE UNITS; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030833858     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/26.4.247     Document Type: Article

References (18)

1. Lake FR, Cullen KJ, de Klerk NH et al. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med 1989; 19: 321-6.
2. Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28: 973-7.
3. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis from randomised controlled trials. Arch Intern Med 1994; 154: 1449-57.
4. Channer KS, Jones JV. Atrial systole: its role in normal and diseased hearts. Clin Sci 1988; 75: 1-4.
5. Channer KS. The drug treatment of atrial fibrillation. Br J Clin Pharmacol 1991; 32: 267-73.
6. Gosselink ATM, Crijns HJGM, van den Berg MP, van den Broek SAJ, Hillege H, Landsman MLJ et al. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br Heart J 1994; 72: 161-6.
7. Van Gelder IC, Crijns HJ, van Gilst WH, Hamer HPM, Lie KI. Decrease of right and left atrial sizes after direct-current electrical cardioversion in chronic atrial fibrillation. Am J Cardiol 1991; 67: 93-5.
8. Lip GYH, Watson RDS, Singh SP. ABC of atrial fibrillation: cardioversion of atrial fibrillation. Br Med J 1996; 312: 112-5.
9. Anon. The antiarrhythmic treatment of atrial fibrillation. Drug Therapeutics Bull 1996; 34: 41-5.
10. Channer KS. Management of recent onset atrial fibrillation. Hospital Update 1994; 20: 437-40.
11. Brodsky MA, Allen BJ, Capparelli EV, Luckett CR, Morton R, Henry WL. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63: 1065-8.
12. Bjerkelund C, Orning OM. An evaluation of dc shock treatment of atrial arrhythmias. Acta Med Scand 1968; 184: 481-91.
13. Eberdt EC, Brill IC, Rogers WR. Value of cardioversion in chronic atrial fibrillation. Arch Intern Med 1967; 119: 253-6.
14. Lee E, Desu M. A computer program for comparing samples with right-censored data. Computer Program Biosci 1972; 2: 315-321.
15. Clark A, Cotter L. Cardioversion in atrial fibrillation. Br J Hosp Med 1993; 49: 256-61.
16. Shapiro EP, Effron MB, Lima S, Ouyang P, Siu CO, Bush D. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 1988; 62: 1202-7.
17. Waris E, Kreus KE, Salokannel J. Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation. Acta Med Scand 1971; 189: 161-6.
18. Carr B, Hawley K, Channer KS. Cardioversion of atrial fibrillation of recent onset with flecainide. Postgrad Med J 1991; 67: 659-62.